NewsBeat: Common Malaria Meds Pose No Undue Risk in Early Pregnancy

Global team finds that artemesinin therapies are as safe as quinine for women in first trimester

By Sarah C.B. Guthrie 

Artemisinin combination therapies (ACTs), medications widely used against malaria, are safe to administer to women in their first trimester of pregnancy, according to research published today. ACTs had previously been recommended at that stage of pregnancy only in life-saving circumstances. 

The Conversation: What Africa Still Needs to Do to Eliminate Malaria

By Willis Simon Akhwale, Country Director for I-TECH Kenya

Malaria is one of the oldest and deadliest infectious diseases affecting man. It is an ancient and modern disease – descriptions of illnesses similar to malaria are found in ancient texts from China, India, the Middle East, Africa and Europe.

Malaria parasites have co-evolved – which involves genetic changes and adaptation – with people as their hosts over a period of four thousand years.

Puget Sound Business Journal: Gates Foundation Invested $545 million in the Seattle area last year

By Coral Garnick

While the Bill and Melinda Gates Foundation is known worldwide and makes contributions around the globe, the Seattle-based nonprofit has made hefty contributions in its hometown.

An economic impact study commissioned by the foundation shows it funneled $545 million into King, Pierce and Snohomish counties in 2015 that translated into $1.5 billion in economic activity.

Fierce Healthcare: Disparate Global Health Spending on the Horizon, Study says

by Paige Minemyer

Global health spending is projected to increase significantly over the next 20 years, but spending rates will likely vary widely between countries, even those of similar size and gross domestic product, a new study has found. Researchers at the University of Washington mapped health spending trends around the world and found huge variation in how much different countries would likely spend, according to data published in The Lancet.

...

HS Newsbeat: How Close are Local Researchers to a Malaria Vaccine?

By Bobbi Nodell and Alex Murphy

As 400,000 people a year are still being killed by malaria, researchers in Seattle are fervently working on a vaccine.

How close are they?

Well, they have several hurdles left but in the next 10 years, there very well could be a malaria vaccine given enough funding, said researchers Stefan Kappe and Jim Kublin, who are working on a vaccine candidate at the Center for Infectious Disease Research (CID Research) in Seattle.

Seattle Times: Millions in Research at UW Could be at Risk in Trump Budget Proposal

The University of Washington has used federal dollars to fund the construction of 15 research buildings in Seattle. Now the Trump administration is talking about slashing that funding.

By Katherine Long

For more than a decade, the University of Washington has used federal research funding to help finance a $1.1 billion building boom in labs and research offices — 15 buildings in all.

But now the Trump administration is talking of sharply curtailing the overhead costs that can be included in research grants.

UW Community Stands Up For Science, Joins Large March in Seattle

Celebrating Earth Day this past weekend, over 20,000 people showed up to March for Science in Seattle on April 22 at Cal Anderson Park. The March lasted four hours, and among the crowd of students, advocates, professors, researchers, parents, concerned citizens, and even WA Governor Jay Inslee, was a large contingency from the University of Washington community.

Pages